Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis
Open Access
- 6 December 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (23)
Abstract
CD141 + DC are implicated in antiviral and antitumor immunity. However, mechanistic studies in autoimmune disease are limited. This is the first study to our knowledge examining CD141 + DC in autoimmune disease, specifically inflammatory arthritis (IA). We identified significant enrichment of CD141 + DC in the inflamed synovial joint, which were transcriptionally distinct from IA and healthy control (HC) blood CD141 + DC and significantly more activated, and they exhibited increased responsiveness to TLR3. Synovial CD141 + DC represent a bone fide CD141 + DC population that is distinct from CD1c + DC. Synovial CD141 + DC induced higher levels of CD4 + and CD8 + T cell activation compared with their peripheral blood counterparts, as made evident by expression of IFN-γ, TNF-α, and granulocyte-macrophage CSF (GMCSF). Autologous synovial CD141 + DC cocultures also induce higher levels of these cytokines, further highlighting their contribution to synovial inflammation. Synovial CD141 + DC–T cell interactions had the ability to further activate synovial fibroblasts, inducing adhesive and invasive pathogenic mechanisms. Furthermore, we identify a mechanism in which synovial CD141 + DC are activated, via ligation of the hypoxia-inducible immune-amplification receptor TREM-1, which increased synovial CD141 + DC activation, migratory capacity, and proinflammatory cytokines. Thus, synovial CD141 + DC display unique mechanistic and transcriptomic signatures, which are distinguishable from blood CD141 + DC and can contribute to synovial joint inflammation.Keywords
Funding Information
- Health Research Board (HRA-POR-2013-328)
- Health Research Board (HRA-POR-2013-328)
This publication has 54 references indexed in Scilit:
- The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cellsCell Communication and Signaling, 2017
- Cell Signaling Pathways That Regulate Antigen PresentationThe Journal of Immunology, 2016
- Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2015
- CD141+ myeloid dendritic cells are enriched in healthy human liverJournal of Hepatology, 2014
- Human Inflammatory Dendritic Cells Induce Th17 Cell DifferentiationImmunity, 2013
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic CellsImmunity, 2012
- F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead CellsImmunity, 2012
- IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell InfiltratesPLOS ONE, 2011
- Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensJournal of Experimental Medicine, 2010
- A Novel Lysosome-Associated Membrane Glycoprotein, DC-LAMP, Induced upon DC Maturation, Is Transiently Expressed in MHC Class II CompartmentImmunity, 1998